Menu
Enrolling by invitation NCT04992650

Ultrasonic Perfusion Imaging in Post-mastectomy Irradiated Patients

No phase Interventional Breast Reconstruction Radiation Dermatitis Radiation Fibrosis Fat Grafting

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Fat grafting.
Who it may be relevant to
Registry conditions: Breast Reconstruction, Radiation Dermatitis, Radiation Fibrosis, Fat Grafting. Basic parameters: from 18 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Ultrasonic Perfusion Imaging for Monitoring Mastectomy Skin Microcirculation in Post-mastectomy Irradiated Patients Before and After Autologous Fat Transfer

Overview

The purpose of this study is to evaluate post-mastectomy breast skin blood supply (perfusion) after radiation therapy, and before and after fat grafting to the breast(s).

Interventions

  • Procedure Fat grafting
    Fat grafting

Primary outcome measures

  • Radiation Fibrosis [Time frame: 12 months]

Eligibility criteria

Inclusion criteria

  • Breast cancer patients undergoing immediate tissue expander or implant reconstruction requiring radiation therapy
  • Have undergone mastectomy

Exclusion criteria

  • Patients who are unwilling to participate

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Non-randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Diagnostic

Study locations

United States · 1 center
  • Mayo Clinic in Rochester — Rochester

Identifiers

NCT: NCT04992650 · 20-001411

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗